Keep this chart in mind. Pregnancy is a prolonged period of cardiovascular stress with increased cardiac output, plasma volume, and heart rate. Things get really interesting during labor/delivery with acute increases in BP and CO.
Various risk scores available: Modified WHO classification, CARPREG II, ZAHARA score. But clinical experience is extremely important since CHD patients are very heterogeneous and may not be well-represented in studies
For preeclampsia prevention, ACOG recommends starting aspirin in high-risk patients. Note: #CHD is *not* considered high risk by this definition, but you don't necessary need to stop ASA for patients who were on it prior to pregnancy.
Specific L&D concerns for #CHD:
-Contractions result in 300-500mL bolus from uterus to circulation
-BP/afterload can ⬇️ w/anesthesia
-Valsalva drives fluctuations in preload
-After delivery, relief of IVC compression results in autotransfusion, ⬆️ venous return, ⬆️ stroke volume
Two examples of systemic right ventricle: D-TGA with atrial switch, and physiologically corrected TGA. How do we predict CV risk during pregnancy and how do we improve said risk?
Fundamental differences between anatomic right and anatomic left ventricle:
-Diff. in myofibril arrangement
-Diff. in 3D geometry
-Tricuspid regurgitation (systemic AV valve) very common in systemic RV
-RV supplied by single coronary ? demand ischemia
-Trad HF tx may not apply
Most recent outcomes data on systemic RV in pregnancy (from @OktayTutarel_MD): No maternal mortality. 10% developed HF, 7% developed arrhythmia. Predictors: pre-pregnancy heart failure, RVEF <40% (Study mostly atrial switch, which is no longer treatment of choice for DTGA)
Best to optimize systemic RV pt *prior* to pregnancy:
-? intervene on TR
-Consider BB, but AVOID ACE-i, ARB, aldosterone antagonists
-Baseline BNP may be useful
Options to treat HF during pregnancy:
-Diuretics
-Deliver?
-Options for afterload reduction: nitrates/hydralazine
Arrhythmias in Pregnancy:
Increasing freq of arrhythmia in pregnancy, partly due to increased maternal age, partly increase in CV risk factors.
Unstable arrhythmia during pregnancy should be cardioverted without delay! DCCV is safe to the baby; only a small amount of energy reaches the fetus. There is a theoretical risk of initiative preterm labor.
Most arrhythmias are pregnancy class C, but adenosine, metoprolol/propranolol, digoxin, lidocaine are considered safe. Amiodarone should be avoided. This graphic is from a great review paper in JACC by @dhalpern10 and @AnneValente1
From @escardio guidelines:
-For pregnant women presenting w/ SVT, try vagal followed by adenosine (unless unstable⚡️)
-If pt w/ WPW don't use CCB or digoxin due to risk of causing Vfib ☠️
-If AF/AFl in pt w/o underlying structural heart disease, think PE! academic.oup.com/eurheartj/arti…
For maternal VT:
-If unstable⚡️
-For VT originating from RVOT, beta-blocker preferred; for fascicular VT, verapamil (I always need an EP doc to determine this!)
-Little evidence in inherited arrhythmia syndromes
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Dr. Lantin giving a Top 10 review of #ACCACPC research in 2020, a truly crazy year! #ACC21
🔟 No mention of 2020 could possibly ignore the effects of the global pandemic on research, patient care, and the way we share knowledge. #COVID19#ACC21
9⃣ Imaging indices correlate with prognosis.
- Transplant/VAD-free survival correlates with MPI-DTI z-score
- Left atrial strain correlates with PCWP and helps identify graft rejection/failure #ACC21
Of interest to the #CHD and #ACHD community, Matthew Gillespie of @HeartCare4Kids, a leader in transcatheter pulmonary valves, gave an update on the state of the art over in the Right Sided Valve Interventions session, and as he rightly points out, it all started with CHD! #ACC21
Who needs pulmonary valve replacement?
👉~40K babies born w/ #CHD each yr
👉~22% have RVOT abnormalities
👉For those w/ RV-PA conduits we've had Melody/Sapien valves
👉For the 85% of RVOT pts w/o conduits with PR, these usu won't work due to dilated/distorted/dynamic RVOTs #ACC21
Work that started ~2004 with Phil Bonhoeffer culminated in first-in-man implantation of a self-expanding RVOT valve reported in 2010 with several devices now available incl. the Medtronic Harmony devices and the Edwards Alterra combined with their Sapien valve in the US. #ACC21
In @abbykhanmd's talk Saturday, she highlighted three commonly used risk models for predicting adverse outcomes in pregnant women with heart disease: the modified WHO criteria, CARPREG II, and ZAHARA. #ACC21
Generally speaking, left-sided obstructive lesions (AS/MS) are known to impart the highest risk, while pulmonary valve disease and aortic regurgitation are regarded as relatively low risk and MR/TR fall somewhere in between. #ACC21
Happy #VivienThomasDay! Today marks 110 years since the birth of Dr. Vivien Thomas. Although he never went to medical school, the surgical techniques he developed, such as the BTT shunt, are the foundation on which congenital heart surgery today was built. #CHD#ESCCongress2020
After graduating from high school, Thomas enrolled at Tennessee Agricultural & Industrial State College (now @TSUedu) as a pre-med. Unfortunately, the Great Depression depleted his savings, so he left college and found work as an assistant in Alfred Blalock's lab at @VUmedicine.
Blalock was doing research in traumatic shock and needed Thomas to help perform surgery on lab animals. Thomas learned quickly, and Blalock gave him more and more independence in the lab. Years later, surgical trainees who worked with Thomas would marvel at his surgical skill.
July 19, 1955, marked the last time that Dr. C. Walton Lillehei carried out a heart operation using the controlled cross-circulation technique. The patient was 5-year-old Paul Mathieu who was born with a ventricular septal defect. Here's a bedtime story for you history buffs...
In the early 1950s, few cardiac anomalies could be corrected or palliated. Valve stenosis had been treated with valvotomy. PDA and CoA had been repaired in 1938 and 1944. And kids with tetralogy of Fallot were being palliated with Blalock-Taussig shunts.
In 1951, the University of Minnesota’s Dr. Clarence Dennis made the first unsuccessful attempts to close atrial septal defects using a heart-lung bypass machine of his own design, but neither patient survived.
On the night of January 6, 1968, @StanfordMed surgeon Norman Shumway transplanted the heart of 43-year-old Virginia White into the chest of 54-year-old Mike Kasperak. It was the first adult heart transplant to be performed in the United States. #medhistory#DonateLife
By 1967, Shumway had already spent over a decade researching heart transplantation. In 1959, he and Richard Lower had performed the world's first successful heart transplant in a dog. Thus it was widely expected that he would be the first to perform a human heart transplant.
On Nov. 20, 1967, Shumway's team announced they were ready to attempt heart transplant in a human. However, just weeks later, on Dec. 3, Christiaan Barnard took the world, and Shumway, by surprise when he reported the world's first human heart transplant.